Volker Diehl (doctor)

from Wikipedia, the free encyclopedia

Volker Diehl (born February 28, 1938 in Berlin ) is a German internist, oncologist and former professor at the University of Cologne .

Life

Diehl had seven siblings and his father was an ENT doctor. After the family was bombed out in the Second War , they fled first to Thuringia, then to Herborn in Hesse. Volker Diehl graduated from high school in Dillenburg in 1958. He studied medicine in Marburg , Vienna and Freiburg im Breisgau . At the Free University of Berlin , he completed his time as a medical assistant . In 1966 he acquired at Theodor Luthard at the University Children's Hospital of the University of Freiburg with the work galactose in HeLa and monkey kidney cell cultures to Dr. med. Further stations in his clinical and scientific training followed: In Philadelphia (USA) he worked with Werner and Gertrude Henle and together with Harald zur Hausen ; in Uganda he worked with Denis Burkitt at Makerere University and in Nairobi, Kenya at the Kenyatta Hospital , collecting serum samples in areas with endemic Burkitt lymphoma for the World Health Organization ; in Stockholm (Sweden) he worked at Karolinska University Hospital . In 1973 Diehl returned to Germany and worked at zur Hausen in Würzburg . Here he laid the foundations for his habilitation thesis Epstein-Barr Virus (EBV) in lymphoid cells: a human tumor virus? (1977). Between 1974 and 1982 Diehl was at the Hannover Medical School . Here he acquired the qualifications for internal medicine and hemato-oncology . In 1983 Diehl received a professorship for internal medicine at the University of Cologne , which he held as director of the University's Medical Clinic I until his retirement in 2003. Parts of the disputed even by Diehl lecture Medical Clinic were included in the Internal Medicine of Gerd Herold .

Diehl is married and has three children.

Act

1967 Diehl was shared with the couple Henle show that the Epstein-Barr virus , the infectious mononucleosis caused. Later he dealt with oncogenic viruses , but above all with malignant diseases of the lymphatic system, in particular the pathogenesis of Hodgkin's disease . In 1978 he succeeded in cultivating a Hodgkin cell line and growing Sternberg giant cells . Diehl founded the German Hodgkin Study Group in 1978, which is considered to be one of the leading groups in research into this clinical picture. Diehl combined basic research and clinical research and was able to make decisive contributions to the understanding of the pathogenesis of Hodgkin's disease as well as significantly improve the therapy of Hodgkin's disease. In 1994 Diehl developed the BEACOPP scheme for the treatment of Hodgkin's disease, assessed stem cell transplantation and developed immunotherapeutic procedures.

Awards

Web links

Individual evidence

  1. ^ Directory of members: Volker Diehl. Academia Europaea, accessed June 21, 2017 .
  2. ^ Gabriele Rutzen: German Cancer Prize for Professor Diehl. University of Cologne, press release from March 20, 1997 at the Informationsdienst Wissenschaft (idw-online.de), accessed on February 12, 2016.
  3. ↑ Member entry by Prof. Dr. Volker Diehl at the German Academy of Sciences Leopoldina , accessed on July 4, 2016.
  4. ↑ Chronicle of the award winners since 1990 (PDF file; 317 kB) at deutsche-hypo.de; Retrieved February 3, 2011
  5. ↑ Magazine 1/2009 (PDF file; 1.0 MB) of the German Cancer Aid (krebshilfe.de); Retrieved February 3, 2012
  6. ↑ Notices (PDF file; 93 kB; accessed on February 3, 2012) of the German Society for Internal Medicine 2007; 102: 695–703 (No. 8), Urban & Vogel, Munich
  7. ↑ Medal winners 1990 to 2017 ; accessed on May 22, 2019.
  8. ↑ Laudation for the award of the Paracelsus Medal to Prof. Dr. med. Dr. hc Volker Diehl at the German Medical Association (bundesaerztekammer.de); accessed on May 22, 2019.
personal data
SURNAME Diehl, Volker
BRIEF DESCRIPTION German oncologist
DATE OF BIRTH February 28, 1938
PLACE OF BIRTH Berlin